Clinical Trial Update: SERS-Based Serum Molecular Spectral Screening for Benign and Malignant Pulmonary Proliferative Nodules

View source ↗

Summary

This trial update describes a study evaluating a SERS-based serum spectral screening approach to distinguish benign from malignant pulmonary nodules in the lung…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Pulmonary Nodules

Snippet

Sponsor: Fuzhou General Hospital | Conditions: Lung Cancer in Normal and Malignant Tumors | Status: NOT_YET_RECRUITING